annual EBITDA:
$220.11M-$20.19M(-8.40%)Summary
- As of today (September 13, 2025), AMPH annual EBITDA is $220.11 million, with the most recent change of -$20.19 million (-8.40%) on December 31, 2024.
- During the last 3 years, AMPH annual EBITDA has risen by +$108.55 million (+97.30%).
- AMPH annual EBITDA is now -8.40% below its all-time high of $240.29 million, reached on December 31, 2023.
Performance
AMPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$58.42M+$5.92M(+11.28%)Summary
- As of today (September 13, 2025), AMPH quarterly EBITDA is $58.42 million, with the most recent change of +$5.92 million (+11.28%) on June 30, 2025.
- Over the past year, AMPH quarterly EBITDA has dropped by -$10.94 million (-15.77%).
- AMPH quarterly EBITDA is now -32.26% below its all-time high of $86.25 million, reached on September 30, 2023.
Performance
AMPH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$242.21M-$10.94M(-4.32%)Summary
- As of today (September 13, 2025), AMPH TTM EBITDA is $242.21 million, with the most recent change of -$10.94 million (-4.32%) on June 30, 2025.
- Over the past year, AMPH TTM EBITDA has dropped by -$43.14 million (-15.12%).
- AMPH TTM EBITDA is now -15.12% below its all-time high of $285.35 million, reached on June 30, 2024.
Performance
AMPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AMPH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.4% | -15.8% | -15.1% |
| 3 y3 years | +97.3% | +83.5% | +98.0% |
| 5 y5 years | +170.2% | +1419.8% | +697.5% |
AMPH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | +97.3% | -32.3% | +90.2% | -15.1% | +98.9% |
| 5 y | 5-year | -8.4% | +629.0% | -32.3% | +1419.8% | -15.1% | +697.5% |
| alltime | all time | -8.4% | +1192.2% | -32.3% | +955.8% | -15.1% | +1436.0% |
AMPH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $58.42M(+11.3%) | $242.21M(-4.3%) |
| Mar 2025 | - | $52.50M(-12.2%) | $253.15M(-3.6%) |
| Dec 2024 | $220.11M(-8.4%) | $59.81M(-16.3%) | $262.62M(-2.9%) |
| Sep 2024 | - | $71.48M(+3.1%) | $270.58M(-5.2%) |
| Jun 2024 | - | $69.36M(+11.9%) | $285.35M(+8.7%) |
| Mar 2024 | - | $61.97M(-8.6%) | $262.61M(+8.8%) |
| Dec 2023 | $240.29M(+64.4%) | $67.77M(-21.4%) | $241.46M(+10.3%) |
| Sep 2023 | - | $86.25M(+85.0%) | $218.96M(+34.0%) |
| Jun 2023 | - | $46.62M(+14.2%) | $163.43M(+9.9%) |
| Mar 2023 | - | $40.83M(-9.8%) | $148.66M(+9.1%) |
| Dec 2022 | $146.16M(+31.0%) | $45.27M(+47.4%) | $136.24M(+11.9%) |
| Sep 2022 | - | $30.72M(-3.5%) | $121.78M(-0.5%) |
| Jun 2022 | - | $31.84M(+12.1%) | $122.34M(+13.4%) |
| Mar 2022 | - | $28.41M(-7.8%) | $107.93M(+11.7%) |
| Dec 2021 | $111.56M(+269.5%) | $30.81M(-1.5%) | $96.65M(+27.9%) |
| Sep 2021 | - | $31.28M(+79.5%) | $75.57M(+38.7%) |
| Jun 2021 | - | $17.43M(+1.7%) | $54.47M(+33.2%) |
| Mar 2021 | - | $17.13M(+76.1%) | $40.89M(+10.3%) |
| Dec 2020 | $30.19M(-62.9%) | $9.73M(-4.5%) | $37.06M(+12.7%) |
| Sep 2020 | - | $10.19M(+165.0%) | $32.89M(+8.3%) |
| Jun 2020 | - | $3.84M(-71.1%) | $30.37M(-8.5%) |
| Mar 2020 | - | $13.30M(+139.4%) | $33.21M(+55.6%) |
| Dec 2019 | $81.47M | $5.56M(-27.6%) | $21.34M(-1.7%) |
| Sep 2019 | - | $7.67M(+14.8%) | $21.70M(+4.9%) |
| Jun 2019 | - | $6.68M(+367.6%) | $20.70M(+35.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $1.43M(-75.9%) | $15.25M(+94.7%) |
| Dec 2018 | $6.83M(-61.8%) | $5.92M(-11.1%) | $7.84M(+75.7%) |
| Sep 2018 | - | $6.67M(+440.1%) | $4.46M(-480.9%) |
| Jun 2018 | - | $1.23M(-120.6%) | -$1.17M(-132.3%) |
| Mar 2018 | - | -$5.99M(-334.9%) | $3.62M(-70.3%) |
| Dec 2017 | $17.89M(-41.0%) | $2.55M(+146.5%) | $12.19M(+41.7%) |
| Sep 2017 | - | $1.03M(-82.8%) | $8.60M(-49.6%) |
| Jun 2017 | - | $6.03M(+133.3%) | $17.08M(-32.0%) |
| Mar 2017 | - | $2.58M(-349.0%) | $25.12M(-18.1%) |
| Dec 2016 | $30.33M(+682.8%) | -$1.04M(-110.9%) | $30.66M(-38.0%) |
| Sep 2016 | - | $9.51M(-32.4%) | $49.47M(+25.0%) |
| Jun 2016 | - | $14.06M(+73.2%) | $39.58M(+111.8%) |
| Mar 2016 | - | $8.12M(-54.3%) | $18.69M(+184.9%) |
| Dec 2015 | $3.88M(-225.4%) | $17.78M(-4765.9%) | $6.56M(-145.6%) |
| Sep 2015 | - | -$381.00K(-94.4%) | -$14.39M(-20.6%) |
| Jun 2015 | - | -$6.83M(+70.3%) | -$18.13M(+117.4%) |
| Mar 2015 | - | -$4.01M(+26.5%) | -$8.34M(+206.7%) |
| Dec 2014 | -$3.09M(-109.9%) | -$3.17M(-23.1%) | -$2.72M(-139.1%) |
| Sep 2014 | - | -$4.12M(-239.1%) | $6.96M(-37.2%) |
| Jun 2014 | - | $2.96M(+84.2%) | $11.09M(+36.5%) |
| Mar 2014 | - | $1.61M(-75.3%) | $8.12M(-31.8%) |
| Dec 2013 | $31.26M(-18.1%) | $6.51M(+20.8%) | $11.90M(+120.8%) |
| Mar 2013 | - | $5.39M | $5.39M |
| Dec 2012 | $38.16M(-289.3%) | - | - |
| Dec 2011 | -$20.15M | - | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of AMPH is $220.11M
What is the all time high annual EBITDA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual EBITDA is $240.29M
What is Amphastar Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, AMPH annual EBITDA has changed by -$20.19M (-8.40%)
What is Amphastar Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of AMPH is $58.42M
What is the all time high quarterly EBITDA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly EBITDA is $86.25M
What is Amphastar Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, AMPH quarterly EBITDA has changed by -$10.94M (-15.77%)
What is Amphastar Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of AMPH is $242.21M
What is the all time high TTM EBITDA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high TTM EBITDA is $285.35M
What is Amphastar Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, AMPH TTM EBITDA has changed by -$43.14M (-15.12%)